Chargement en cours...
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant. Design Propensity weighted (inverse probability of treatment weighted...
Enregistré dans:
| Publié dans: | BMJ |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group Ltd.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5421446/ https://ncbi.nlm.nih.gov/pubmed/28188243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.j510 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|